SEOM-GGCC clinical guidelines for the prophylaxis of infectious diseases in patients with cancer (UPDATE 2026).

IF 2.7 3区医学 Q2 ONCOLOGY

Clinical & Translational Oncology Pub Date : 2026-10-15 DOI:10.1007/s12094-026-04578-0

Isabel Echavarria, Jesús Corral, María Pilar Diz Taín, Fernando Henao Carrasco, Vega Iranzo González-Cruz, Xabier Mielgo-Rubio, Teresa Quintanar, Carlos Rivas Corredor, Pedro Pérez Segura

引用次数: 0

Abstract

Infections are still a major cause of morbidity and mortality in patients with cancer. Some of these infections are preventable through specific measures, such as vaccination or prophylaxis. This guideline (updated in 2026) aims to summarize the current evidence and recommendations for the prevention of infections in patients with cancer, devoting special attention to the most prevalent preventable infectious diseases. All of the evidence is graded according to The Infectious Diseases Society of America grading system.

查看原文本刊更多论文

SEOM-GGCC癌症患者传染病预防临床指南（UPDATE 2026）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical & Translational Oncology 医学-肿瘤学

CiteScore

6.20

自引率

2.90%

发文量

240

审稿时长

1 months

期刊介绍： Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of new targets for cancer therapy, and new technologies for research and treatment of cancer are the major themes covered by the educational series. Full research articles on a broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.